Company Filing History:
1 out of 822 
1 out of 167 
Years Active: 2025
Title: Charles S Locke: Innovator in Pharmaceutical Formulations
Introduction
Charles S Locke is an accomplished inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of unique formulations that enhance the administration of essential medications.
Latest Patents
Locke holds a patent for "Pharmaceutical formulations for subcutaneous administration." This patent focuses on compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which are formulated in a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through subcutaneous administration of these compositions.
Career Highlights
Throughout his career, Locke has worked with notable companies in the pharmaceutical industry, including AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
Locke has collaborated with several professionals in his field, including Ehab Moussa and Matthew Rosebraugh. These partnerships have contributed to the advancement of his research and the successful implementation of his patented formulations.
Conclusion
Charles S Locke is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to the treatment of Parkinson's disease. His work continues to impact the lives of many patients through improved medication delivery methods.